OS Cancer Research Results
OS, overall survival: Click to Expand ⟱
| Source: |
| Type: |
Overall survival
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *eff↑, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
| - |
in-vivo, |
ALS, |
NA |
|
|
|
- |
NA, |
Stroke, |
NA |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
- |
NA, |
Park, |
NA |
|
|
|
*eff↑, *ROS↓, *GSH↑, *NRF2↑, *motorD↑, *OS↑, *neuroP↑, *BBB↑, *cognitive↑, *eff↑, *antiOx↑, *Cyt‑c↑, *PGC-1α↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
- |
NA, |
Diabetic, |
NA |
|
|
|
- |
NA, |
Stroke, |
NA |
|
|
|
- |
NA, |
LiverDam, |
NA |
|
|
|
- |
NA, |
Park, |
NA |
|
|
|
*mtDam↓, *BioAv↝, *BioAv↑, *OS↑, *eff↑, *eff↑, *cognitive↑, *DNAdam↓, *SIRT1↑, *cardioP↑, *ROS↓, *Dose↝, *BioAv↑, *hepatoP↑, *eff↑, *BG↓, *creat↓,
| - |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*hepatoP↑, *Inflam↓, *neuroP↑, *antiOx↑, *angioG↑, *cardioP↑, *BioAv↑, *P450↓, *eff↑, *BioAv↑, E-cadherin↓, ER(estro)↓, MMP2↓, MMP9↓, VEGF↓, cMyc↓, BAX↑, P53↑, TumCG↓, OS↑, *cognitive↑, *GSK‐3β↓, *GSH↑, *Casp3↓, *Casp9↓, *Cyt‑c↓, *lipid-P↓, *motorD↑, *AChE↓, *memory↑, *cardioP↑, *ROS↓, *PPARγ↑, *ALAT↓, *AST↓, *ALP↓, *AMPK↑, *5HT↑, *SIRT1↑, *eff↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*OS↑, *memory↑, *cognitive↑, *memory↑, *Aβ↓, *eff↑, *HSF1↑, *HSP70/HSPA5↑,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
HO-1↑, 1, NRF2↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
mitResp↓, 1, mtDam↑, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 2, Glycolysis↓, 1,
Cell Death ⓘ
Akt↓, 1, BAX↑, 1, Bax:Bcl2↑, 1, Casp3↑, 1, Casp9↑, 1,
DNA Damage & Repair ⓘ
P53↑, 1, p‑P53↑, 1, PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, cycD1/CCND1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↝, 1, p‑GSK‐3β↓, 1, mTOR↓, 1, PI3K↓, 1, TumCG↓, 2,
Migration ⓘ
E-cadherin↓, 1, E-cadherin↑, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, VEGF↓, 2,
Hormonal & Nuclear Receptors ⓘ
ER(estro)↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1,
Functional Outcomes ⓘ
OS↑, 2,
Total Targets: 34
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 3, Catalase↑, 1, GPx↑, 1, GSH↑, 3, HO-1↑, 1, lipid-P↓, 1, MDA↓, 1, NRF2↑, 3, ROS↓, 4, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
mtDam↓, 1, PGC-1α↑, 1,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 1, AMPK↑, 2, glucose↓, 1, LDH↓, 1, PPARα↝, 1, PPARγ↑, 1, SIRT1↑, 2,
Cell Death ⓘ
Casp↓, 1, Casp3↓, 1, Casp9↓, 1, Cyt‑c↓, 1, Cyt‑c↑, 1, JNK↓, 1,
Protein Folding & ER Stress ⓘ
HSF1↑, 1, HSP70/HSPA5↑, 1,
DNA Damage & Repair ⓘ
DNAdam↓, 1,
Proliferation, Differentiation & Cell State ⓘ
GSK‐3β↓, 1,
Migration ⓘ
Ca+2↓, 1, TRPC1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↑, 1, Hif1a↓, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IL6↓, 1, Inflam↓, 2, NF-kB↓, 2, TLR4↓, 1, TNF-α↓, 1,
Synaptic & Neurotransmission ⓘ
5HT↑, 1, AChE↓, 2,
Protein Aggregation ⓘ
Aβ↓, 2,
Drug Metabolism & Resistance ⓘ
BioAv↑, 4, BioAv↝, 1, Dose↝, 1, eff↑, 9, P450↓, 1,
Clinical Biomarkers ⓘ
ALAT↓, 1, ALP↓, 1, AST↓, 1, BG↓, 1, BP↓, 1, creat↓, 1, IL6↓, 1, LDH↓, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 1, cardioP↑, 4, cognitive↑, 4, hepatoP↑, 3, memory↑, 4, motorD↑, 2, neuroP↑, 4, OS↑, 3,
Total Targets: 64
Scientific Paper Hit Count for: OS, overall survival
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:229 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page